In RA, IL-10 inhibits the expression of the proinflammatory factor TNF-ɑ, prevents osteoclast activation, and reduces the degree of joint swelling, and as a result, this cytokine inhibits the progression of inflammation, relieves cartilage degradation, and exerts immunomodulatory effects [69]. This evidence concerns the gene IL10 and rheumatoid arthritis.